Sandoz shares dip on first day of Swiss listing after Novartis spinoff
Novartis has completed a spinoff of its generics and biosimilars arm Sandoz, which made its debut earlier today on the SIX …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
